Liver Injury/Regeneration News

The majority of liver transplant recipients are able to produce a functional antibody response to COVID-19 infection, according to data published in Gut.

Healio presents the following report on the top 10 hepatology peer-tested articles from 2021.

People with a parent, sibling or child with diabetes have increased risk for developing nonalcoholic fatty liver disease, or NAFLD, regardless of their own glucose status, according to study findings.

The CDC’s Advisory Committee on Immunization Practices recently issued a universal recommendation that all adults aged 19 to 59 years receive the hepatitis B vaccine.

Patients with nonalcoholic fatty liver disease and liver-involved fibrosis frequently had a cholestatic pattern that increased the risk for liver-related events, according to a presentation at The Liver Meeting Digital Experience.

When primary care physicians interact with virtual specialists in hepatology, more of their patients have improved survival rate beyond the initial consultation, according to a presenter at The Liver Meeting Digital Experience.

Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.

Pegbelfermin was safe and effective in improving markers of steatosis, fibrosis and inflammation among patients with nonalcoholic steatohepatitis with stage 3 fibrosis, according to a presentation at The Liver Meeting Digital Experience.

Increased awareness is needed to mitigate burden fatty liver disease and modifiable risk factors among adolescents and young adults, according to research presented at The Liver Meeting Digital Experience.

COVID-19 vaccination correlated with a decreased risk for hospitalization among patients with cirrhosis and other high-risk comorbidities, according to research presented at The Liver Meeting Digital Experience.